Biotech Biogen surges on Alzeimers drug approval
MELBOURNE: A biotech has jumped on NASDAQ following approval of a Biogen Inc. Alzheimer’s drug…. read more
Ansell names Neil Salmon as new CEO for global group
MELBOURNE: Ansell has named the head of its industrial global business unit Neil Salmon as… read more
Macquarie facing ASIC probe into $1.8b Nuix float
SYDNEY: Investment banking giant Macquarie Group is facing further reputational damage from its financial backing… read more
